Snowball logo
logo
SZLS_logo

StageZero Life Sciences Ltd

SZLS β€’ TO
CA$0.04CA$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
0.1387044.151815.0681563.7950762.882252.026926
COGS
1.0996153.4562553.8906724.1988232.8719011.601613
Gross Profit
(0.960911)0.6955551.177484(0.403747)0.01040.425314
Operating Expenses & Income
Operating Income
(5.112951)(3.699036)(8.130842)(7.746761)(4.608665)(2.046838)
Total Operating Expenses
4.1793284.0507119.3083267.3430167.4909172.878763
R&D Expenses
-0.2186960.7745360.3519920.09590.0197
Selling General & Admin Expenses
4.1793284.0210456.9786855.9057324.1180322.417107
Earnings from Continuing Operations
Interest Expense
(0.803198)(0.320422)(0.200308)(0.284069)(0.325348)(0.121573)
Interest Income
1.60808-----
Income Tax Expense
0.8304860.3204220.2003083.297109-0.0676
Net Income
Net Income
(4.312288)(7.184365)(7.684226)(11.42)(12.53)(2.152907)
Supplemental
EBIT
(5.112951)(3.699036)(8.130842)(11.2)--
EBITDA
(4.814864)(3.482705)(7.621567)(10.76)--
In millions of CAD, except % and values per 1 share